1-3 of 3
A. John Barrett
Close
Sort by
Journal Articles

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

Clinical Trials & Observations
Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant, Maja Stanojevic, C. Russell Cruz, Michael Keller, Maria Fernanda Fortiz, Fahmida Hoq, Haili Lang, A. John Barrett, Hua Liang, Jay Tanna, Nan Zhang, Abeer Shibli, Anushree Datar, Kenneth Fulton, Divyesh Kukadiya, Anqing Zhang, Kirsten M. Williams, Hema Dave, Jeffrey S. Dome, David Jacobsohn, Patrick J. Hanley, Richard J. Jones, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2520–2534.
https://doi.org/10.1182/bloodadvances.2021006831
Published: 2022
Includes: Supplemental data
Journal Articles

Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier

Clinical Trials & Observations
Christian P. Bradley, Cai Chen, Karolyn A. Oetjen, Cheng Yan, Reema Panjwani, Sara Hauffe, Katherine R. Calvo, Constance Yuan, Prapti Arvind Patel, Nathan D. Montgomery, Matthew C. Foster, Minoo Battiwalla, A. John Barrett, Richard J. Gibbons, Sawa Ito
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2627–2631.
https://doi.org/10.1182/bloodadvances.2019000013
Published: 2019
Includes: Supplemental data
Journal Articles

Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab

Clinical Trials & Observations
Catherine Lai, Vishal Ranpura, Colin Wu, Matthew J. Olnes, Ankur R. Parikh, Aarthi Shenoy, Julie Thompson, Barbara Weinstein, Phillip Scheinberg, A. John Barrett, Ronan Desmond, Neal S. Young, Christopher S. Hourigan
Journal: Blood Advances
Blood Adv (2019) 3 (7): 980–983.
https://doi.org/10.1182/bloodadvances.2018030411
Published: 2019
Includes: Supplemental data